Nonmyeloablative Hematopoietic Cell Transplantation
Lyle Feinstein(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), George E. Georges(Northwestern University), David G. Maloney(Fred Hutch Cancer Center), Jerry Radich(University of Washington), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas R. Chauncey(City Of Hope National Medical Center), Ann E. Woolfrey(University of Washington), Hans‐Peter Kiem(Fred Hutch Cancer Center), Jan Maciej Zaucha(Gdańsk Medical University), Christopher R. Flowers(The University of Texas MD Anderson Cancer Center), Brenda M. Sandmaier(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Karl G. Blume(City Of Hope National Medical Center), Marie-Térèse Little(Scripps Research Institute), Michael B. Maris(Colorado Blood Cancer Institute), Richard A. Nash(Colorado Blood Cancer Institute), JUDITH SHIZURU(Stanford University)
Cited by 75
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k